Comment
. 2001 Jun 15;19(12):3157-8; author reply 3158-9.
doi: 10.1200/JCO.2001.19.12.3157.
Assessing adjuvant breast cancer therapy benefit
- PMID: 11408515
- DOI: 10.1200/JCO.2001.19.12.3157
Item in Clipboard
Comment
Assessing adjuvant breast cancer therapy benefit
J Clin Oncol.
.
No abstract available
Comment on
-
Understanding the utility of adjuvant systemic therapy for primary breast cancer.J Clin Oncol. 2001 Feb 15;19(4):972-9. doi: 10.1200/JCO.2001.19.4.972. J Clin Oncol. 2001. PMID: 11181659
-
Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.J Clin Oncol. 2001 Mar 1;19(5):1468-75. doi: 10.1200/JCO.2001.19.5.1468. J Clin Oncol. 2001. PMID: 11230493
Similar articles
-
Assessing adjuvant breast cancer therapy benefit.J Clin Oncol. 2001 Jun 15;19(12):3158-9. J Clin Oncol. 2001. PMID: 11417570 No abstract available.
-
Adjuvant chemotherapy in early breast cancer.Dan Med J. 2016 May;63(5):B5222. Dan Med J. 2016. PMID: 27127018 Review.
-
[Clinical studies of adjuvant systemic chemotherapy in breast cancer in The Netherlands assumes a greater number of patients than is available].Ned Tijdschr Geneeskd. 1995 Aug 5;139(31):1599-602. Ned Tijdschr Geneeskd. 1995. PMID: 7675145 Dutch.
-
Prediction of benefit from adjuvant treatment in patients with breast cancer.Clin Breast Cancer. 2010;10 Suppl 1:E32-7. doi: 10.3816/CBC.2010.s.005. Clin Breast Cancer. 2010. PMID: 20587405
-
Adjuvant therapy for breast cancer.NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. NIH Consens Statement. 2000. PMID: 11512506 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
